Pyxis Oncology Inc (PYXS)
4.34
-0.17
(-3.77%)
USD |
NASDAQ |
May 10, 16:00
4.39
+0.05
(+1.15%)
After-Hours: 20:00
Pyxis Oncology Enterprise Value: 133.00M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 133.00M |
| May 09, 2024 | 142.88M |
| May 08, 2024 | 128.93M |
| May 07, 2024 | 135.33M |
| May 06, 2024 | 131.26M |
| May 03, 2024 | 135.33M |
| May 02, 2024 | 137.07M |
| May 01, 2024 | 136.49M |
| April 30, 2024 | 139.40M |
| April 29, 2024 | 138.81M |
| April 26, 2024 | 130.68M |
| April 25, 2024 | 130.68M |
| April 24, 2024 | 139.40M |
| April 23, 2024 | 142.30M |
| April 22, 2024 | 144.05M |
| April 19, 2024 | 122.54M |
| April 18, 2024 | 144.05M |
| April 17, 2024 | 161.49M |
| April 16, 2024 | 153.35M |
| April 15, 2024 | 156.25M |
| April 12, 2024 | 166.72M |
| April 11, 2024 | 187.06M |
| April 10, 2024 | 176.02M |
| April 09, 2024 | 191.72M |
| April 08, 2024 | 205.09M |
| Date | Value |
|---|---|
| April 05, 2024 | 198.11M |
| April 04, 2024 | 179.51M |
| April 03, 2024 | 204.50M |
| April 02, 2024 | 193.46M |
| April 01, 2024 | 159.16M |
| March 28, 2024 | 128.35M |
| March 27, 2024 | 124.86M |
| March 26, 2024 | 103.35M |
| March 25, 2024 | 92.89M |
| March 22, 2024 | 112.65M |
| March 21, 2024 | 169.04M |
| March 20, 2024 | 196.37M |
| March 19, 2024 | 111.19M |
| March 18, 2024 | 100.00M |
| March 15, 2024 | 109.85M |
| March 14, 2024 | 92.84M |
| March 13, 2024 | 120.14M |
| March 12, 2024 | 135.80M |
| March 11, 2024 | 140.73M |
| March 08, 2024 | 132.67M |
| March 07, 2024 | 159.52M |
| March 06, 2024 | 161.76M |
| March 05, 2024 | 169.37M |
| March 04, 2024 | 170.27M |
| March 01, 2024 | 175.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-180.80M
Minimum
May 13 2022
313.13M
Maximum
Nov 04 2021
-33.79M
Average
-55.01M
Median
Nov 03 2023
Enterprise Value Benchmarks
| Apyx Medical Corp | 41.72M |
| Nortech Systems Inc | 48.95M |
| Phio Pharmaceuticals Corp | -5.255M |
| X4 Pharmaceuticals Inc | 150.29M |
| Monogram Orthopaedics Inc | 45.88M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.60M |
| Total Expenses (Quarterly) | 17.77M |
| EPS Diluted (Quarterly) | -0.33 |
| Earnings Yield | -42.40% |